Tides Medical
Private Company
Total funding raised: $12.5M
Overview
Tides Medical is a private, commercial-stage company specializing in human amniotic tissue-based regenerative products for chronic wounds and surgical procedures. Its vertically integrated business encompasses tissue acquisition via its Louisiana Organization for Transplant (LOFT), aseptic processing and terminal sterilization in its AATB-accredited tissue bank, and a nationwide distribution network supported by a dedicated sales and reimbursement service team. The company's value proposition centers on providing high-quality, easy-to-use grafts coupled with exceptional customer support to remove administrative barriers for physicians, thereby improving patient access to advanced treatment options. Tides appears to be revenue-generating, serving a national market from its headquarters in Lafayette, Louisiana.
Technology Platform
Proprietary aseptic processing, terminal radiation sterilization, and preservation of human amniotic membrane for room-temperature stable biological grafts.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Tides competes in the crowded amniotic tissue and regenerative medicine market against larger public companies (e.g., Organogenesis with its NuShield/BioClaim products, MiMedx) and numerous private firms. Its primary competitive differentiation is not just the product, but its integrated service model focusing on reimbursement support. Competitors may have broader product portfolios or greater financial resources for R&D and marketing.